Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
Lidia Ciccone, Jennifer Vandooren, Susanna Nencetti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 86-86
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Activatable Probes for Ratiometric Imaging of Endogenous Biomarkers In Vivo
Qinrui Fu, Xiao Yang, Mengzhen Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 3916-3968
Closed Access | Times Cited: 32
Ketogenic diet alleviates cognitive dysfunction and neuroinflammation in APP/PS1 mice via the Nrf2/HO-1 and NF-κB signaling pathways
Jingwen Jiang, Hong Pan, Fanxia Shen, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2767-2772
Open Access | Times Cited: 25
Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 16
Protective effect of a hydromethanolic extract from Fraxinus excelsior L. bark against a rat model of aluminum chloride-induced Alzheimer's disease: Relevance to its anti-inflammatory and antioxidant effects
Amin Iranpanah, Sajad Fakhri, Gholamreza Bahrami, et al.
Journal of Ethnopharmacology (2024) Vol. 323, pp. 117708-117708
Closed Access | Times Cited: 13
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting
Nabil Mohie Abdel‐Hamid, Shimaa A. Abass
Molecular Biology Reports (2021) Vol. 48, Iss. 9, pp. 6525-6538
Closed Access | Times Cited: 50
Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer’s disease models
Feng Zhang, Shi Jing-shan, Daidi Li, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 5, pp. 972-972
Open Access | Times Cited: 42
The Role of Extracellular Matrix in Human Neurodegenerative Diseases
Panka Pintér, Alán Alpár
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11085-11085
Open Access | Times Cited: 30
Role of Matrix Metalloproteinases in Musculoskeletal Diseases
Lokender Kumar, Monish Bisen, Azhar Abbas Khan, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2477-2477
Open Access | Times Cited: 28
Natural product-based pharmacological studies for neurological disorders
Vivek Puri, Neha Kanojia, Ameya Sharma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Zinc Homeostasis: An Emerging Therapeutic Target for Neuroinflammation Related Diseases
Shunfeng Liu, Nan Wang, Yaqian Long, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 416-416
Open Access | Times Cited: 16
Marine Pharmacology in 2019–2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action
Alejandro M. S. Mayer, Veronica A. Mayer, Michelle Swanson‐Mungerson, et al.
Marine Drugs (2024) Vol. 22, Iss. 7, pp. 309-309
Open Access | Times Cited: 6
Exploitation of Marine Molecules to Manage Alzheimer’s Disease
Marisa Silva, Paula Seijas, Paz Otero
Marine Drugs (2021) Vol. 19, Iss. 7, pp. 373-373
Open Access | Times Cited: 29
Modulating Effects of Zingiberaceae Phenolic Compounds on Neurotrophic Factors and Their Potential as Neuroprotectants in Brain Disorders and Age-Associated Neurodegenerative Disorders: A Review
Azraul Mumtazah Razak, Jen Kit Tan, Mazlina Mohd Said, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2564-2564
Open Access | Times Cited: 12
Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
Dandan Chu, Xingyue Yang, Jing Wang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1221-1232
Open Access | Times Cited: 10
Polydatin attenuates Alzheimer’s disease induced by aluminum chloride in rats: evidence for its antioxidant and anti-inflammatory effects
Seyede Nazanin Zarneshan, Sajad Fakhri, Amir Kiani, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation
Marwa El‐Hussieny, Mansoura A. Abd‐El‐Maksoud, Fouad M. Soliman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
Spectroscopic and computational studies on the binding interaction of biologically active thioridazine and perphenazine with human Matrix metalloproteinases 9
Simin Khataee, Leila Sadeghi, Mahya Hosseinpour Feizi, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138548-138548
Closed Access | Times Cited: 3
Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease
Lidia Ciccone, Susanna Nencetti, Armando Rossello, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1036-1036
Open Access | Times Cited: 7
Nano-PSO Administration Attenuates Cognitive and Neuronal Deficits Resulting from Traumatic Brain Injury
Doaa Qubty, Kati Frid, Meirav Har‐Even, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2725-2725
Open Access | Times Cited: 10
Multifunctional Small Molecules as Potential Anti-Alzheimer’s Disease Agents
Beatrice Bargagna, Lidia Ciccone, Susanna Nencetti, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 6015-6015
Open Access | Times Cited: 11
Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy
S. Maurya, Divya Prasad, Sayali Mukherjee
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 3-17
Closed Access | Times Cited: 4
Recent Molecular Targets and Their Ligands for the Treatment of Alzheimer Disease
Gülşah Bayraktar, Vildan Alptüzün
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 28, pp. 2447-2464
Closed Access | Times Cited: 1
Bacopa monnieri for Disorders Affecting Brain: Current Perspectives
Adithya Vinod, S. Sathianarayanan, Anju Elizabath Babu, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 23, pp. 1909-1929
Closed Access | Times Cited: 6
Antioxidant Quercetin 3-O-Glycosylated Plant Flavonols Contribute to Transthyretin Stabilization
Lidia Ciccone, Nicolò Tonali, Carole Fruchart‐Gaillard, et al.
Crystals (2022) Vol. 12, Iss. 5, pp. 638-638
Open Access | Times Cited: 6
Cyclic peptides as an inhibitor of metastasis in breast cancer targeting MMP-1: Computational approach
Md. Maruf Hasan, Abu Rashed Md. Shawon, Abdullah Aeyas, et al.
Informatics in Medicine Unlocked (2022) Vol. 35, pp. 101128-101128
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top